In terms of market side, this report researches the Hormonal Contraceptive revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
The global Hormonal Contraceptive market size in 2022 is 16600.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 4.60% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Hormonal Contraceptive market include Abbvie, Inc (U.S.), Afaxys, Inc. (U.S.), Merck & Co Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), and Bayer AG (Germany). The share of the top 3 players in the Hormonal Contraceptive market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Hormonal Contraceptive market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Male accounted for XX% of Hormonal Contraceptive market in 2022. Female share of XX%.
Hospitals accounted for XX% of the Hormonal Contraceptive market in 2022. Homecare accounts for XX%.
Report Includes:
This report presents an overview of global market for Hormonal Contraceptive. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key players of Hormonal Contraceptive, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Hormonal Contraceptive, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hormonal Contraceptive market share and industry ranking of main players, data from 2018 to 2023. Identification of the major stakeholders in the global Hormonal Contraceptive market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, from 2018 to 2029. Evaluation and forecast the market size for Hormonal Contraceptive sales, projected growth trends, technology, application and end-user industry.
With the development of the economy, the improvement of residents' consumption level and the upgrade of consumption structure, the food and beverage industry as a whole has shown a good growth trend. In the future, the production capacity will continue to expand, and the industrial structure will be further improved and optimized.
E-Commerce Growth: The growth of e-commerce has significantly impacted the food and beverage industry. Online grocery shopping and food delivery services have witnessed tremendous growth, especially during the COVID-19 pandemic. Companies have been investing in online platforms and expanding their digital presence to cater to changing consumer preferences.
Clean label and transparency: Consumers are increasingly seeking transparency in food products. Clean label initiatives emphasize the use of natural ingredients, removal of artificial additives, and clear and accurate labeling to provide consumers with more information about the food they consume.
Regions Covered in This Report Are
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico
Some of the Top Key Players:
Abbvie, Inc (U.S.)
Afaxys, Inc. (U.S.)
Merck & Co Inc. (U.S.)
Teva Pharmaceuticals Industries Ltd. (Israel)
Bayer AG (Germany)
Pfizer Inc. (U.S.)
Agile Therapeutics (U.S.)
Cupid Ltd. (India)
Helm AG (Germany)
Church & Dwight Co., Inc (U.S.)
Organon group of companies (U.S.)
Reckitt Benckiser Group PLC (U.K.)
Veru Inc. (U.S.)
Boehringer Ingelheim International GmbH (Germany)
Novartis AG (Switzerland)
Lupin (India)
Glenmark Pharmaceuticals (India)
Product Types Outlook
Male
Female
Application Outlook
Hospitals
Homecare
Clinics
Gynecology Centers
Ambulatory Surgical Centers (ASC)
Table of Content
1 Hormonal Contraceptive Market Introduction and Overview
1.1 Hormonal Contraceptive Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Hormonal Contraceptive Sales and Market Share by Manufacturer
2.2 Global Hormonal Contraceptive Revenue and Market Share by Manufacturer
2.3 Global Hormonal Contraceptive Average Price by Manufacturers
2.4 Manufacturers Hormonal Contraceptive Production Sites, Area Served, Product Types
2.5 Hormonal Contraceptive Market Competitive Situation and Trends
2.5.1 Hormonal Contraceptive Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2023
2.5.3 Mergers & Acquisitions, Expansion
3 Global Hormonal Contraceptive Historical Market Analysis by Type
3.1 Market Size Analysis by Types
3.1.4 Global Hormonal Contraceptive Market Share by Type 2018 VS 2022
3.2 Global Hormonal Contraceptive Revenue and Market Share by Type
3.3 Global Hormonal Contraceptive Sales and Market Share by Type
4 Global Hormonal Contraceptive Historical and Forecast Market Analysis by Application
4.1 Market Size Analysis by Application
4.1.4 Global Hormonal Contraceptive Market Share by Application 2018 VS 2022
4.2 Global Hormonal Contraceptive Revenue Market Share by Application (2018-2023)
4.3 Global Hormonal Contraceptive Sales Market Share by Application (2018-2023)
5 Global Market Growth Trends Analysis
5.1 Global Hormonal Contraceptive Market Size (2018-2023)
5.2 Hormonal Contraceptive Growth Trends Analysis by Regions
5.2.1 Hormonal Contraceptive Market Size by Regions: 2018 VS 2023 VS 2029
5.2.2 Hormonal Contraceptive Historic Revenue Market Size by Regions (2018-2023)
5.2.3 Hormonal Contraceptive Historic Sales Market Size by Regions (2018-2023)
5.3 North America
5.3.1 North America Hormonal Contraceptive Revenue by Countries (2018-2023)
5.3.2 North America Hormonal Contraceptive Sales by Countries (2018-2023)
5.3.3 North America SWOT Analysis
5.3.4 United States
5.3.5 Canada
5.4 China
5.4.1 China SWOT Analysis
5.5 Asia Pacific (Excluding China)
5.5.1 Asia Pacific Hormonal Contraceptive Revenue by Countries (2018-2023)
5.5.2 Asia Pacific Hormonal Contraceptive Sales by Countries (2018-2023)
5.5.3 Asia Pacific SWOT Analysis
5.5.4 Japan
5.5.5 Korea
5.5.6 Southeast Asia
5.5.7 India
5.5.8 Australia
5.6 EMEA
5.6.1 EMEA Hormonal Contraceptive Revenue by Countries (2018-2023)
5.6.2 EMEA Hormonal Contraceptive Sales by Countries (2018-2023)
5.6.3 EMEA SWOT Analysis
5.6.4 Europe
5.6.5 Middle East
5.6.6 Africa
5.7 Latin America
5.7.1 Latin America Hormonal Contraceptive Revenue by Countries (2018-2023)
5.7.2 Latin America Hormonal Contraceptive Sales by Countries (2018-2023)
5.7.3 Latin America SWOT Analysis
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Mexico
6 Players Profiles
6.1 Abbvie, Inc (U.S.)
6.1.1 Abbvie, Inc (U.S.) Company Profile
6.1.2 Hormonal Contraceptive Product Overview
6.1.3 Abbvie, Inc (U.S.) Hormonal Contraceptive Market Performance (2018-2023)
6.1.4 Abbvie, Inc (U.S.) Business Overview
6.1.5 SWOT Analysis
6.2 Afaxys, Inc. (U.S.)
6.2.1 Afaxys, Inc. (U.S.) Company Profile
6.2.2 Hormonal Contraceptive Product Overview
6.2.3 Afaxys, Inc. (U.S.) Hormonal Contraceptive Market Performance (2018-2023)
6.2.4 Afaxys, Inc. (U.S.) Business Overview
6.2.5 SWOT Analysis
6.3 Merck & Co Inc. (U.S.)
6.3.1 Merck & Co Inc. (U.S.) Company Profile
6.3.2 Hormonal Contraceptive Product Overview
6.3.3 Merck & Co Inc. (U.S.) Hormonal Contraceptive Market Performance (2018-2023)
6.3.4 Merck & Co Inc. (U.S.) Business Overview
6.3.5 SWOT Analysis
6.4 Teva Pharmaceuticals Industries Ltd. (Israel)
6.4.1 Teva Pharmaceuticals Industries Ltd. (Israel) Company Profile
6.4.2 Hormonal Contraceptive Product Overview
6.4.3 Teva Pharmaceuticals Industries Ltd. (Israel) Hormonal Contraceptive Market Performance (2018-2023)
6.4.4 Teva Pharmaceuticals Industries Ltd. (Israel) Business Overview
6.4.5 SWOT Analysis
6.5 Bayer AG (Germany)
6.5.1 Bayer AG (Germany) Company Profile
6.5.2 Hormonal Contraceptive Product Overview
6.5.3 Bayer AG (Germany) Hormonal Contraceptive Market Performance (2018-2023)
6.5.4 Bayer AG (Germany) Business Overview
6.5.5 SWOT Analysis
6.6 Pfizer Inc. (U.S.)
6.6.1 Pfizer Inc. (U.S.) Company Profile
6.6.2 Hormonal Contraceptive Product Overview
6.6.3 Pfizer Inc. (U.S.) Hormonal Contraceptive Market Performance (2018-2023)
6.6.4 Pfizer Inc. (U.S.) Business Overview
6.6.5 SWOT Analysis
6.7 Agile Therapeutics (U.S.)
6.7.1 Agile Therapeutics (U.S.) Company Profile
6.7.2 Hormonal Contraceptive Product Overview
6.7.3 Agile Therapeutics (U.S.) Hormonal Contraceptive Market Performance (2018-2023)
6.7.4 Agile Therapeutics (U.S.) Business Overview
6.7.5 SWOT Analysis
6.8 Cupid Ltd. (India)
6.8.1 Cupid Ltd. (India) Company Profile
6.8.2 Hormonal Contraceptive Product Overview
6.8.3 Cupid Ltd. (India) Hormonal Contraceptive Market Performance (2018-2023)
6.8.4 Cupid Ltd. (India) Business Overview
6.8.5 SWOT Analysis
6.9 Helm AG (Germany)
6.9.1 Helm AG (Germany) Company Profile
6.9.2 Hormonal Contraceptive Product Overview
6.9.3 Helm AG (Germany) Hormonal Contraceptive Market Performance (2018-2023)
6.9.4 Helm AG (Germany) Business Overview
6.9.5 SWOT Analysis
6.10 Church & Dwight Co., Inc (U.S.)
6.10.1 Church & Dwight Co., Inc (U.S.) Company Profile
6.10.2 Hormonal Contraceptive Product Overview
6.10.3 Church & Dwight Co., Inc (U.S.) Hormonal Contraceptive Market Performance (2018-2023)
6.10.4 Church & Dwight Co., Inc (U.S.) Business Overview
6.10.5 SWOT Analysis
6.11 Organon group of companies (U.S.)
6.11.1 Organon group of companies (U.S.) Company Profile
6.11.2 Hormonal Contraceptive Product Overview
6.11.3 Organon group of companies (U.S.) Hormonal Contraceptive Market Performance (2018-2023)
6.11.4 Organon group of companies (U.S.) Business Overview
6.11.5 SWOT Analysis
6.12 Reckitt Benckiser Group PLC (U.K.)
6.12.1 Reckitt Benckiser Group PLC (U.K.) Company Profile
6.12.2 Hormonal Contraceptive Product Overview
6.12.3 Reckitt Benckiser Group PLC (U.K.) Hormonal Contraceptive Market Performance (2018-2023)
6.12.4 Reckitt Benckiser Group PLC (U.K.) Business Overview
6.12.5 SWOT Analysis
6.13 Veru Inc. (U.S.)
6.13.1 Veru Inc. (U.S.) Company Profile
6.13.2 Hormonal Contraceptive Product Overview
6.13.3 Veru Inc. (U.S.) Hormonal Contraceptive Market Performance (2018-2023)
6.13.4 Veru Inc. (U.S.) Business Overview
6.13.5 SWOT Analysis
6.14 Boehringer Ingelheim International GmbH (Germany)
6.14.1 Boehringer Ingelheim International GmbH (Germany) Company Profile
6.14.2 Hormonal Contraceptive Product Overview
6.14.3 Boehringer Ingelheim International GmbH (Germany) Hormonal Contraceptive Market Performance (2018-2023)
6.14.4 Boehringer Ingelheim International GmbH (Germany) Business Overview
6.14.5 SWOT Analysis
6.15 Novartis AG (Switzerland)
6.15.1 Novartis AG (Switzerland) Company Profile
6.15.2 Hormonal Contraceptive Product Overview
6.15.3 Novartis AG (Switzerland) Hormonal Contraceptive Market Performance (2018-2023)
6.15.4 Novartis AG (Switzerland) Business Overview
6.15.5 SWOT Analysis
6.16 Lupin (India)
6.16.1 Lupin (India) Company Profile
6.16.2 Hormonal Contraceptive Product Overview
6.16.3 Lupin (India) Hormonal Contraceptive Market Performance (2018-2023)
6.16.4 Lupin (India) Business Overview
6.16.5 SWOT Analysis
6.17 Glenmark Pharmaceuticals (India)
6.17.1 Glenmark Pharmaceuticals (India) Company Profile
6.17.2 Hormonal Contraceptive Product Overview
6.17.3 Glenmark Pharmaceuticals (India) Hormonal Contraceptive Market Performance (2018-2023)
6.17.4 Glenmark Pharmaceuticals (India) Business Overview
6.17.5 SWOT Analysis
7 Hormonal Contraceptive Manufacturing Cost Analysis
7.1 Hormonal Contraceptive Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hormonal Contraceptive
7.4 Hormonal Contraceptive Industrial Chain Analysis
8 Market Channel, Distributors, Traders and Dealers
8.1 Market Channel Status
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.2 Hormonal Contraceptive Typical Distributors
8.3 Hormonal Contraceptive Typical Customers
9 Hormonal Contraceptive Industry Dynamic Analysis
9.1 Hormonal Contraceptive Market Trends Analysis
9.2 Hormonal Contraceptive Market Drivers Analysis
9.3 Hormonal Contraceptive Market Challenges Analysis
9.4 Hormonal Contraceptive Market Restraints Analysis
10 Global Hormonal Contraceptive Forecast Market Analysis by Type & Application
10.1 Global Hormonal Contraceptive Revenue Market Forecast by Type (2023-2029)
10.2 Global Hormonal Contraceptive Sales Market Forecast by Type (2023-2029)
10.3 Hormonal Contraceptive Revenue Market Forecast by Application (2023-2029)
10.4 Hormonal Contraceptive Sales Market Forecast by Application (2023-2029)
11 Global Hormonal Contraceptive Forecast Market Analysis by Region
11.1 Hormonal Contraceptive Revenue Market Forecast by Region (2023-2029)
11.2 Hormonal Contraceptive Sales Market Forecast by Region (2023-2029)
11.3 North America Hormonal Contraceptive Forecast Market Analysis
11.4 EMEA Hormonal Contraceptive Forecast Market Analysis
11.5 China Hormonal Contraceptive Forecast Market Analysis
11.6 Asia-Pacific Hormonal Contraceptive Forecast Market Analysis
11.7 Latin America Hormonal Contraceptive Forecast Market Analysis
12 Research Findings and Conclusion
List of Tables and Figures
Figure Hormonal Contraceptive Picture
Table Product Definition of Hormonal Contraceptive
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Table Global Hormonal Contraceptive Sales by Manufacturer (2018-2023)
Table Global Hormonal Contraceptive Sales Market Share by Manufacturer (2018-2023)
Figure Global Hormonal Contraceptive Sales Market Share by Manufacturer in 2023
Table Global Hormonal Contraceptive Revenue ($) by Manufacturer (2018-2023)
Table Global Hormonal Contraceptive Revenue Market Share by Manufacturer (2018-2023)
Figure Global Hormonal Contraceptive Revenue Market Share by Manufacturer in 2023
Table Global Hormonal Contraceptive Price by Manufacturer (2018-2023)
Table Manufacturers Hormonal Contraceptive Production Sites, Area Served, Product Types
Table Hormonal Contraceptive Market Concentration Rate
Figure Global Top 5 and Top 10 Players Market Share by Revenue in 2023
Table Mergers & Acquisitions, Expansion Plans
Table Global Hormonal Contraceptive Market Size by Type (2023 VS 2029)
Figure Global Hormonal Contraceptive Market Share by Type 2018 VS 2022
Table Global Hormonal Contraceptive Revenue and Market Size by Type (2018-2023)
Table Global Hormonal Contraceptive Revenue and Market Share by Type (2018-2023)
Table Global Hormonal Contraceptive Sales and Market Size by Type (2018-2023)
Table Global Hormonal Contraceptive Sales and Market Share by Type (2018-2023)
Table Global Hormonal Contraceptive Market Size by Application (2023 VS 2029)
Figure Global Hormonal Contraceptive Market Share by Application 2018 VS 2022
Table Global Hormonal Contraceptive Revenue Market Size by Application (2018-2023)
Table Global Hormonal Contraceptive Revenue Market Share by Application (2018-2023)
Table Global Hormonal Contraceptive Sales Market Size by Application (2018-2023)
Table Global Hormonal Contraceptive Sales Market Share by Application (2018-2023)
Figure Global Hormonal Contraceptive Revenue Market Size (2018-2023)
Figure Global Hormonal Contraceptive Sales Market Size (2018-2023)
Table Hormonal Contraceptive Market Size by Regions: 2018 VS 2023 VS 2029
Table Hormonal Contraceptive Historic Revenue Market Size by Regions (2018-2023)
Table Hormonal Contraceptive Historic Revenue Market Share by Regions (2018-2023)
Table Hormonal Contraceptive Historic Sales Market Size by Regions (2018-2023)
Table Hormonal Contraceptive Historic Sales Market Share by Regions (2018-2023)
Figure North America Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure North America Hormonal Contraceptive Sales and Growth (2018-2023)
Table North America Hormonal Contraceptive Revenue by Countries (2018-2023)
Table North America Hormonal Contraceptive Revenue Market Share by Countries (2018-2023)
Table North America Hormonal Contraceptive Sales by Countries (2018-2023)
Table North America Hormonal Contraceptive Sales Market Share by Countries (2018-2023)
Table North America SWOT Analysis
Figure United States Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure United States Hormonal Contraceptive Sales and Growth (2018-2023)
Figure Canada Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure Canada Hormonal Contraceptive Sales and Growth (2018-2023)
Table China SWOT Analysis
Figure China Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure China Hormonal Contraceptive Sales and Growth (2018-2023)
Figure Asia Pacific Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure Asia Pacific Hormonal Contraceptive Sales and Growth (2018-2023)
Table Asia-Pacific Hormonal Contraceptive Revenue by Countries (2018-2023)
Table Asia-Pacific Hormonal Contraceptive Revenue Market Share by Countries (2018-2023)
Table Asia-Pacific Hormonal Contraceptive Sales by Countries (2018-2023)
Table Asia-Pacific Hormonal Contraceptive Revenue Market Share by Countries (2018-2023)
Table Asia Pacific SWOT Analysis
Figure Japan Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure Japan Hormonal Contraceptive Sales and Growth (2018-2023)
Figure Korea Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure Korea Hormonal Contraceptive Sales and Growth (2018-2023)
Figure Southeast Asia Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure Southeast Asia Hormonal Contraceptive Sales and Growth (2018-2023)
Figure India Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure India Hormonal Contraceptive Sales and Growth (2018-2023)
Figure Australia Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure Australia Hormonal Contraceptive Sales and Growth (2018-2023)
Figure EMEA Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure EMEA Hormonal Contraceptive Sales and Growth (2018-2023)
Table EMEA Hormonal Contraceptive Revenue by Countries (2018-2023)
Table EMEA Hormonal Contraceptive Revenue Market Share by Countries (2018-2023)
Table EMEA Hormonal Contraceptive Sales by Countries (2018-2023)
Table EMEA Hormonal Contraceptive Sales Market Share by Countries (2018-2023)
Table EMEA SWOT Analysis
Figure Europe Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure Europe Hormonal Contraceptive Sales and Growth (2018-2023)
Figure Germany Hormonal Contraceptive Revenue and Growth (2018-2029)
Figure Germany Hormonal Contraceptive Sales and Growth (2018-2029)
Figure France Hormonal Contraceptive Revenue and Growth (2018-2029)
Figure France Hormonal Contraceptive Sales and Growth (2018-2029)
Figure UK Hormonal Contraceptive Revenue and Growth (2018-2029)
Figure UK Hormonal Contraceptive Sales and Growth (2018-2029)
Figure Italy Hormonal Contraceptive Revenue and Growth (2018-2029)
Figure Italy Hormonal Contraceptive Sales and Growth (2018-2029)
Figure Russia Hormonal Contraceptive Revenue and Growth (2018-2029)
Figure Russia Hormonal Contraceptive Sales and Growth (2018-2029)
Figure Nordic Hormonal Contraceptive Revenue and Growth (2018-2029)
Figure Nordic Hormonal Contraceptive Sales and Growth (2018-2029)
Figure Middle East Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure Middle East Hormonal Contraceptive Sales and Growth (2018-2023)
Figure Africa Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure Africa Hormonal Contraceptive Sales and Growth (2018-2023)
Figure Latin America Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure Latin America Hormonal Contraceptive Sales and Growth (2018-2023)
Table Latin America Hormonal Contraceptive Revenue by Countries (2018-2023)
Table Latin America Hormonal Contraceptive Revenue Market Share by Countries (2018-2023)
Table Latin America Hormonal Contraceptive Sales by Countries (2018-2023)
Table Latin America Hormonal Contraceptive Sales Market Share by Countries (2018-2023)
Table Latin America SWOT Analysis
Figure Brazil Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure Brazil Hormonal Contraceptive Sales and Growth (2018-2023)
Figure Argentina Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure Argentina Hormonal Contraceptive Sales and Growth (2018-2023)
Figure Mexico Hormonal Contraceptive Revenue and Growth (2018-2023)
Figure Mexico Hormonal Contraceptive Sales and Growth (2018-2023)
Table Abbvie, Inc (U.S.) Profile
Table Product Overview
Table Abbvie, Inc (U.S.) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Abbvie, Inc (U.S.) Sales and Growth Rate
Figure Abbvie, Inc (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Afaxys, Inc. (U.S.) Profile
Table Product Overview
Table Afaxys, Inc. (U.S.) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Afaxys, Inc. (U.S.) Sales and Growth Rate
Figure Afaxys, Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Merck & Co Inc. (U.S.) Profile
Table Product Overview
Table Merck & Co Inc. (U.S.) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Merck & Co Inc. (U.S.) Sales and Growth Rate
Figure Merck & Co Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Teva Pharmaceuticals Industries Ltd. (Israel) Profile
Table Product Overview
Table Teva Pharmaceuticals Industries Ltd. (Israel) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Teva Pharmaceuticals Industries Ltd. (Israel) Sales and Growth Rate
Figure Teva Pharmaceuticals Industries Ltd. (Israel) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Bayer AG (Germany) Profile
Table Product Overview
Table Bayer AG (Germany) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Bayer AG (Germany) Sales and Growth Rate
Figure Bayer AG (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Pfizer Inc. (U.S.) Profile
Table Product Overview
Table Pfizer Inc. (U.S.) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Pfizer Inc. (U.S.) Sales and Growth Rate
Figure Pfizer Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Agile Therapeutics (U.S.) Profile
Table Product Overview
Table Agile Therapeutics (U.S.) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Agile Therapeutics (U.S.) Sales and Growth Rate
Figure Agile Therapeutics (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Cupid Ltd. (India) Profile
Table Product Overview
Table Cupid Ltd. (India) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Cupid Ltd. (India) Sales and Growth Rate
Figure Cupid Ltd. (India) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Helm AG (Germany) Profile
Table Product Overview
Table Helm AG (Germany) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Helm AG (Germany) Sales and Growth Rate
Figure Helm AG (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Church & Dwight Co., Inc (U.S.) Profile
Table Product Overview
Table Church & Dwight Co., Inc (U.S.) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Church & Dwight Co., Inc (U.S.) Sales and Growth Rate
Figure Church & Dwight Co., Inc (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Organon group of companies (U.S.) Profile
Table Product Overview
Table Organon group of companies (U.S.) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Organon group of companies (U.S.) Sales and Growth Rate
Figure Organon group of companies (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Reckitt Benckiser Group PLC (U.K.) Profile
Table Product Overview
Table Reckitt Benckiser Group PLC (U.K.) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Reckitt Benckiser Group PLC (U.K.) Sales and Growth Rate
Figure Reckitt Benckiser Group PLC (U.K.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Veru Inc. (U.S.) Profile
Table Product Overview
Table Veru Inc. (U.S.) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Veru Inc. (U.S.) Sales and Growth Rate
Figure Veru Inc. (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Boehringer Ingelheim International GmbH (Germany) Profile
Table Product Overview
Table Boehringer Ingelheim International GmbH (Germany) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Boehringer Ingelheim International GmbH (Germany) Sales and Growth Rate
Figure Boehringer Ingelheim International GmbH (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Novartis AG (Switzerland) Profile
Table Product Overview
Table Novartis AG (Switzerland) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Novartis AG (Switzerland) Sales and Growth Rate
Figure Novartis AG (Switzerland) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Lupin (India) Profile
Table Product Overview
Table Lupin (India) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Lupin (India) Sales and Growth Rate
Figure Lupin (India) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Table Glenmark Pharmaceuticals (India) Profile
Table Product Overview
Table Glenmark Pharmaceuticals (India) Hormonal Contraceptive Sales, Price, Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Glenmark Pharmaceuticals (India) Sales and Growth Rate
Figure Glenmark Pharmaceuticals (India) Revenue Market Share 2017-2022
Table Business Overview
Table SWOT Analysis
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Proportion of Manufacturing Cost Structure
Figure Manufacturing Process Analysis of Hormonal Contraceptive
Figure Hormonal Contraceptive Industrial Chain Analysis
Table Distributors of Hormonal Contraceptive with Contact Information
Table Major Customers of Hormonal Contraceptive with Contact Information
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Global Hormonal Contraceptive Revenue Market Size Forecast by Type (2023-2029)
Table Global Hormonal Contraceptive Revenue Market Share Forecast by Type (2023-2029)
Table Global Hormonal Contraceptive Sales Market Size Forecast by Type (2023-2029)
Table Global Hormonal Contraceptive Sales Market Share Forecast by Type (2023-2029)
Table Global Hormonal Contraceptive Revenue Market Size by Application (2023-2029)
Table Global Hormonal Contraceptive Revenue Market Share by Application (2023-2029)
Table Global Hormonal Contraceptive Sales Market Size by Application (2023-2029)
Table Global Hormonal Contraceptive Sales Market Share by Application (2023-2029)
Table Global Hormonal Contraceptive Revenue Market Size by Region (2023-2029)
Table Global Hormonal Contraceptive Revenue Market Share by Region (2023-2029)
Table Global Hormonal Contraceptive Sales Market Size by Region (2023-2029)
Table Global Hormonal Contraceptive Sales Market Share by Region (2023-2029)
Figure North America Hormonal Contraceptive Forecast Revenue and Growth 2023-2029
Figure North America Hormonal Contraceptive Forecast Sales and Growth 2023-2029
Figure EMEA Hormonal Contraceptive Forecast Revenue and Growth 2023-2029
Figure EMEA Hormonal Contraceptive Forecast Sales and Growth 2023-2029
Figure China Hormonal Contraceptive Forecast Revenue and Growth 2023-2029
Figure China Hormonal Contraceptive Forecast Sales and Growth 2023-2029
Figure Asia-Pacific Hormonal Contraceptive Forecast Revenue and Growth 2023-2029
Figure Asia-Pacific Hormonal Contraceptive Forecast Sales and Growth 2023-2029
Figure Latin America Hormonal Contraceptive Forecast Revenue and Growth 2023-2029
Figure Latin America Hormonal Contraceptive Forecast Sales and Growth 2023-2029
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|